18.64
-0.01 (-0.05%)
Previous Close | 18.65 |
Open | 18.81 |
Volume | 23,958 |
Avg. Volume (3M) | 82,782 |
Market Cap | 156,317,264 |
Price / Earnings (TTM) | 23.59 |
Price / Earnings (Forward) | 23.75 |
Price / Sales | 3.44 |
Price / Book | 4.78 |
52 Weeks Range | |
Earnings Date | 26 Aug 2025 |
Profit Margin | 11.65% |
Operating Margin (TTM) | 13.64% |
Diluted EPS (TTM) | 0.790 |
Quarterly Revenue Growth (YOY) | 13.10% |
Quarterly Earnings Growth (YOY) | 26.70% |
Total Debt/Equity (MRQ) | 0.25% |
Current Ratio (MRQ) | 5.19 |
Operating Cash Flow (TTM) | 12.02 M |
Levered Free Cash Flow (TTM) | 12.07 M |
Return on Assets (TTM) | 11.04% |
Return on Equity (TTM) | 16.56% |
Market Trend
Short Term | Medium Term | ||
Industry | Medical Devices (US) | Bearish | Bearish |
Medical Devices (Global) | Bearish | Bearish | |
Stock | Electromed, Inc. | Mixed | - |
AIStockmoo Score
Analyst Consensus | -2.0 |
Insider Activity | NA |
Price Volatility | 4.5 |
Technical Moving Averages | -1.0 |
Technical Oscillators | 2.0 |
Average | 0.88 |
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products primarily to home health care and institutional markets for patients with bronchiectasis, cystic fibrosis, and neuromuscular diseases. It markets its products primarily to physicians and health care providers, as well as directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota. |
|
Sector | Healthcare |
Industry | Medical Devices |
% Held by Insiders | 20.96% |
% Held by Institutions | 51.63% |
No data within this time range.
No data within this time range.
Date | Type | Details |
---|---|---|
26 Aug 2025 | Announcement | Electromed, Inc. Announces Record Fiscal 2025 Fourth Quarter and Full Year Financial Results |
12 Aug 2025 | Announcement | Electromed, Inc. to Report Q4 Fiscal 2025 Financial Results on August 26, 2025 |
29 Jul 2025 | Announcement | Electromed, Inc. to Participate in the Canaccord Genuity 45th Annual Growth Conference |
25 Jun 2025 | Announcement | Q2 Virtual Investor Summit: Presentations Available Now |
09 Jun 2025 | Announcement | Electromed, Inc. to Present at the Investor Summit Virtual on June 10, 2025 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |